Quantinuum (NASDAQ:QNT) Stock Gets Price Target Cut from JPMorgan Chase & Co.

Key Points

• JPMorgan cut Quantinuum’s price target to $80 from $97 but maintained its Overweight rating; the new target implies 112.94% upside from the share price cited in the report.
• Several other firms also lowered targets, including Needham ($100 to $60) and Cantor Fitzgerald ($90 to $55). Despite the cuts, analysts’ consensus rating remains Moderate Buy, with an average target of $87.15.
• Quantinuum beat quarterly earnings expectations, reporting a loss of $0.29 per share versus the expected $0.99 loss, while revenue rose 233% year over year to $9.05 million; it also raised its full-year revenue outlook.

Quantinuum (NASDAQ:QNT - Get Free Report) had its price target reduced by equities research analysts at JPMorgan Chase & Co. from $97.00 to $80.00 in a research report issued on Friday, Benzinga reports. The firm currently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 112.94% from the stock's current price.

A number of other brokerages have also recently commented on QNT. Needham & Company LLC cut their price target on shares of Quantinuum from $100.00 to $60.00 and set a "buy" rating for the company in a research note on Friday. Sanford C. Bernstein restated a "hold" rating on shares of Quantinuum in a research note on Wednesday, August 12th. Jefferies Financial Group set a $85.00 target price on shares of Quantinuum in a report on Wednesday, August 12th. Cantor Fitzgerald cut their target price on shares of Quantinuum from $90.00 to $55.00 and set an "overweight" rating for the company in a research note on Friday. Finally, Morgan Stanley upgraded Quantinuum from an "equal weight" rating to an "overweight" rating and reduced their price target for the stock from $78.00 to $62.00 in a report on Thursday, October 15th. Thirteen equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Quantinuum presently has a consensus rating of "Moderate Buy" and an average price target of $87.15.

Quantinuum Price Performance

Shares of NASDAQ QNT traded up $7.75 during trading hours on Friday, hitting $37.57. The company had a trading volume of 5,035,251 shares, compared to its average volume of 2,310,149. The stock has a market capitalization of $9.89 billion and a PE ratio of -134.18. Quantinuum has a 1-year low of $28.31 and a 1-year high of $86.79. The firm's 50 day moving average price is $43.74.

Quantinuum (NASDAQ:QNT - Get Free Report) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share for the quarter, beating the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million during the quarter. Equities research analysts expect that Quantinuum will post -4.76 EPS for the current year.

Institutional Investors Weigh In On Quantinuum

Several hedge funds have recently added to or reduced their stakes in the business. CoreCap Advisors LLC bought a new position in Quantinuum in the 3rd quarter valued at about $32,000. Fifth Third Bancorp boosted its holdings in shares of Quantinuum by 1,530.2% during the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company's stock worth $49,000 after acquiring an additional 964 shares during the period. IFP Advisors Inc grew its position in shares of Quantinuum by 1,150.0% in the third quarter. IFP Advisors Inc now owns 1,250 shares of the company's stock valued at $60,000 after purchasing an additional 1,150 shares during the last quarter. Steel Grove Capital Advisors LLC grew its position in shares of Quantinuum by 25.6% in the third quarter. Steel Grove Capital Advisors LLC now owns 5,992 shares of the company's stock valued at $288,000 after purchasing an additional 1,222 shares during the last quarter. Finally, Russell Investments Group Ltd. bought a new position in shares of Quantinuum during the third quarter worth approximately $97,000.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum's software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.